Climb Bio, Inc. (CLYM) Misses Q1 EPS by 16c
Tweet
Share
E-mailGet Alerts CLYM Hot Sheet
Join SI Premium – FREE
Climb Bio, Inc. (NASDAQ: CLYM) reported Q1 EPS of ($0.31), $0.16 worse than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan cuts estimates for Circle and Coinbase on Hyperliquid pressure
- Estimating Edge Explores the Connection Between Estimating and Construction Safety Management
- Iran Says It Must Control Entire Hormuz Strait In Wartime - IRIB
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
